Event driven snapshot of GE HealthCare Technologies stock

GE HealthCare Technologies (GEHC) has been drawing attention after recent share price moves, with the stock up about 7.1% over the past week and 5.5% over the past month, while showing a 12.5% decline over the past 3 months.

At a share price of $74.67, GE HealthCare Technologies has seen short term momentum soften compared with earlier weakness, with a 1 year total shareholder return of 18.61% contrasting with a 3 year total shareholder return of 10.26%.

If you are comparing GE HealthCare Technologies with other names shaping medical technology and diagnostics, it can be useful to scan a wider universe of healthcare related AI opportunities via 34 healthcare AI stocks

With GE HealthCare trading at $74.67 and an indicated intrinsic discount of about 33%, plus a price target gap of around 22%, the key question is simple: is there real value left here, or is future growth already priced in?

Most Popular Narrative: 18.6% Undervalued

At $74.67, the most followed narrative on GE HealthCare points to a fair value near $91.74, setting up a clear valuation gap driven by detailed earnings and revenue assumptions.

The pipeline of new high-impact products, like Radiopharmaceuticals, Total Body PET, and Photon Counting CT, is anticipated to drive future revenue growth and potentially improve margins.

Curious what kind of growth profile could support that fair value gap? The narrative leans on steady revenue expansion, firmer margins, and a future earnings multiple that contrasts with today. The full breakdown shows how those pieces fit together without assuming explosive growth.

The same narrative framework also assumes consistent progress on recurring digital and visualization revenue, plus disciplined use of capital, all filtered through an 8.49% discount rate to arrive at that $91.74 figure. See our AI narrative and valuation for GE HealthCare Technologies.

Result: Fair Value of $91.74 (UNDERVALUED)

However, this hinges on tariff and China related risks staying contained, and on free cash flow not being held back for too long by inventory and cost pressures.

Next Steps

Given the mix of opportunities and concerns discussed so far, it makes sense to look past the headlines and weigh the data yourself. If you want a clearer picture of what the market is balancing right now, review the 5 key rewards and 1 important warning sign

Looking for more investment ideas?

If GE HealthCare Technologies is on your radar, do not stop here. Broaden your watchlist with a few focused stock ideas that match your style and risk comfort.

• Target potential mispricing by scanning companies that combine quality fundamentals with compressed valuations using the 57 high quality undervalued stocks.
• Strengthen your income focus by zeroing in on companies with robust payouts and higher yields through the 12 dividend fortresses.
• Prioritise resilience by reviewing companies that score well on financial stability and risk through the 74 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.